Fresh analysis suggests that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who stop conventional diet and exercise programs.
Research printed in a prominent health publication points out that while overweight individuals can lose substantial amounts of their total mass while on the medication, the mass is regained at an average rate of 0.8 kg per month after stopping.
"People purchasing these medications need to be informed of the risk of fast weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of regain suggests a return to pre-treatment mass within about a year and a half.
Comparing Treatments
The study, which reviewed 37 of trials involving thousands of patients, compared the results of these new drugs with conventional dieting.
Researchers point out that individuals who lose weight through diet and exercise generally have a more gradual creep back—around 100 grams monthly—after stopping.
The Reason for the Fast Regain
Nutrition scientists propose the way of the jabs explains the amplified regain.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this hormone supplement results in appetite is uncontrolled, making overeating much more probable."
An Ongoing Condition?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, considering the significant potential of weight regain, the therapy should be considered life-long.
This view is supported by pharmaceutical companies, who note that the findings "underscore the chronic character of obesity," akin to managing diseases like high blood pressure.
Patient Accounts
People who have come off the medication describe a powerful return of cravings.
"It was like something flipping and I was suddenly ravenous," recalled an individual.
This challenge is worsened if individuals have not established permanent dietary or behavioural changes during treatment.
Significant Use
Recent estimates indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is greater among women compared to males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
Ultimately, clinicians stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent cure and long-term success likely depends on ongoing behavioural changes.